Prevalence of Uropathogenic Escherichia coli Among Different Age Groups
DOI:
https://doi.org/10.46966/msjar.v6i2.286Keywords:
Prevalence, UPEC, E. coli, Age groups, UTIAbstract
Escherichia coli is a significant reason for urinary tract infections (UTIs) especially in immunocompromised individuals such as pregnant women, elderly people, and youngsters. Therefore, this cross-sectional research initiative to detect the prevalence of uropathogenic E. coli (UPEC) to understand its impact and spread among patients with UTIs across different age groups. The current study was conducted between October 2024 and March 2025, with 155 urine samples collected from outpatients. Microscopical, cultural, and biochemical examinations revealed that 78 out of 155 samples (50.3%) were E. coli. All UPEC isolates showed a green metallic sheen on Endo agar and Eosin Methylene Blue (EMB) agar, and a blue colour on Chrome agar. Of the 78 UPEC isolates, 60 (76.9%) were female, and 18 (23.0%) were male. The percentage of UPEC isolates in females was greater in the 21-30-year age group 18 (24.3%), while in males it was greater in the 51-60-year age group 4 (5.1%). Official health institutions must assume responsibility for raising awareness of the importance of hygiene and rationalizing the consumption and use of antibiotics.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Baneen M. Alkurdi, Miaad K. Alkhudhairy
This work is licensed under a Creative Commons Attribution 4.0 International License.
In submitting the manuscript to the Medical Science Journal for Advance Research, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal.
- That it is not under consideration for publication elsewhere,
- The publication has been approved by the author(s) and by responsible authorities – tacitly or explicitly – of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
License and Copyright Agreement
Authors who publish with Medical Science Journal for Advance Research agree to the following terms:
- Authors retain copyright and grant the Medical Science Journal for Advance Research right of first publication with the work simultaneously licensed under Creative Commons Attribution License (CC BY 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the Medical Science Journal for Advance Research published version of the work (e.g., post it to an institutional repository or edit it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
